glutathione benefits liver What is and why must we protect patient access to it? Glutathione in the Treatment of

Ingredients:Deionized Water, Glycerin, Propanediol 1,3, Dimethyl Isosorbide, Polyacrylate Crosspolymer-6, Copper Tripeptide-1, Matrixyl 3000 (Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7), Argireline (Acetyl Hexapeptide-8), Palmitoyl Pentapeptide-4, Phenoxyethanol, Caprylyl Glycol

What the Research Does NOT Yet Support - There are currently no published randomised controlled trials (RCTs) in humans for BPC-157 - Human pharmacokinetic data (how it is absorbed, distributed, metabolised, and excreted) is limited - Optimal dosing, route of administration, and treatment duration have not been established clinically - Long-term safety data in humans is absent - Regulatory approval from the TGA, FDA, or EMA has not been granted for any therapeutic indication TB-500: Evidence Overview What the Research Supports TB-500 / Thymosin Beta-4 has somewhat more human-facing research, though still predominantly preclinical: Phase I and II clinical trials have investigated Thymosin Beta-4 (the native peptide) in cardiac repair following myocardial infarction, with promising safety profiles Wound healing applications have been explored in clinical settings, particularly for chronic non-healing wounds and dry eye disease Robust animal evidence supports its role in reducing inflammation, supporting angiogenesis, and promoting tissue regeneration The native peptide (T4) has demonstrated cardioprotective effects in animal models of heart failure and ischaemia What the Research Does NOT Yet Support TB-500 is a synthetic fragment of T4 it is not identical to the native peptide, and extrapolating human clinical data from T4 studies directly to TB-500 may not be valid No approved therapeutic indications exist for TB-500 specifically Comparative efficacy versus established treatments has not been studied The long-term effects of exogenous peptide administration on endogenous thymosin beta-4 regulation are unknown Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited

Green Beans Green beans contain 230 nM of glutathione per gram

It does not constitute medical, legal, or therapeutic advice and is not intended to suggest personal use, dosing, or human application

Not a marginal improvement

Chronic Bladder Pain A 2024 pilot study looked at 12 women with a painful bladder condition called interstitial cystitis